Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy

ClinicalTrials.gov ID: NCT01220609

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT01220609. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 10:27 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Evaluation of Ixabepilone (NSC #710428) in the Treatment of Recurrent or Persistent Leiomyosarcoma of the Uterus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This phase II trial is studying the side effects and how well ixabepilone works in treating patients with recurrent or persistent leiomyosarcoma of the uterus previously treated with chemotherapy. Drugs used in chemotherapy, such as ixabepilone, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.

Study identification

NCT ID
NCT01220609
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
26 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2010 (Type not available)
Primary completion
Jul 2014 (Actual)
Completion
Jan 2016 (Actual)
Last update posted
Aug 8, 2019

2010 – 2016

United States locations

U.S. sites
72
U.S. states
27
U.S. cities
57
Facility City State ZIP Site status
Gynecologic Oncology Group of Arizona Phoenix Arizona 85012 —
University of Arkansas for Medical Sciences Little Rock Arkansas 72205 —
Los Angeles County-USC Medical Center Los Angeles California 90033 —
USC / Norris Comprehensive Cancer Center Los Angeles California 90033 —
University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora Colorado 80045 —
Hartford Hospital Hartford Connecticut 06102 —
Saint Francis Hospital and Medical Center Hartford Connecticut 06105 —
The Hospital of Central Connecticut New Britain Connecticut 06050 —
Florida Gynecologic Oncology Fort Myers Florida 33905 —
John B Amos Cancer Center Columbus Georgia 31904 —
Saint Alphonsus Cancer Care Center-Boise Boise Idaho 83706 —
Rush University Medical Center Chicago Illinois 60612 —
University of Chicago Comprehensive Cancer Center Chicago Illinois 60637 —
Sudarshan K Sharma MD Limted-Gynecologic Oncology Hinsdale Illinois 60521 —
Advocate Christ Medical Center Oak Lawn Illinois 60453-2699 —
Cadence Cancer Center in Warrenville Warrenville Illinois 60555 —
Saint Vincent Oncology Center Indianapolis Indiana 46260 —
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 —
Greater Baltimore Medical Center Baltimore Maryland 21204 —
Saint Joseph Mercy Hospital Ann Arbor Michigan 48106-0995 —
Michigan Cancer Research Consortium Community Clinical Oncology Program Ann Arbor Michigan 48106 —
Oakwood Hospital and Medical Center Dearborn Michigan 48124 —
Henry Ford Hospital Detroit Michigan 48202 —
Saint John Hospital and Medical Center Detroit Michigan 48236 —
Hurley Medical Center Flint Michigan 48502 —
Genesys Regional Medical Center-West Flint Campus Flint Michigan 48532 —
Allegiance Health Jackson Michigan 49201 —
Borgess Medical Center Kalamazoo Michigan 49001 —
Bronson Methodist Hospital Kalamazoo Michigan 49007 —
West Michigan Cancer Center Kalamazoo Michigan 49007 —
Sparrow Hospital Lansing Michigan 48912 —
Saint Mary Mercy Hospital Livonia Michigan 48154 —
Saint Joseph Mercy Oakland Pontiac Michigan 48341 —
Saint Joseph Mercy Port Huron Port Huron Michigan 48060 —
Saint Mary's of Michigan Saginaw Michigan 48601 —
Saint John Macomb-Oakland Hospital Warren Michigan 48093 —
Singing River Hospital Pascagoula Mississippi 39581 —
Phelps County Regional Medical Center Rolla Missouri 65401 —
Saint John's Clinic-Rolla-Cancer and Hematology Rolla Missouri 65401 —
Mercy Hospital Springfield Springfield Missouri 65804 —
Ozark Health Ventures LLC-Cancer Research for The Ozarks Springfield Springfield Missouri 65804 —
CoxHealth South Hospital Springfield Missouri 65807 —
Washington University School of Medicine St Louis Missouri 63110 —
Nebraska Methodist Hospital Omaha Nebraska 68114 —
Women's Cancer Center of Nevada Las Vegas Nevada 89169 —
Cooper Hospital University Medical Center Camden New Jersey 08103 —
Carolinas Medical Center Charlotte North Carolina 28203 —
Novant Health Presbyterian Medical Center Charlotte North Carolina 28204 —
Summa Akron City Hospital/Cooper Cancer Center Akron Ohio 44304 —
Case Western Reserve University Cleveland Ohio 44106 —
Cleveland Clinic Cancer Center/Fairview Hospital Cleveland Ohio 44111 —
Cleveland Clinic Foundation Cleveland Ohio 44195 —
Riverside Methodist Hospital Columbus Ohio 43214 —
Hillcrest Hospital Cancer Center Mayfield Heights Ohio 44124 —
Lake University Ireland Cancer Center Mentor Ohio 44060 —
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 —
Tulsa Cancer Institute Tulsa Oklahoma 74146 —
Abington Memorial Hospital Abington Pennsylvania 19001 —
Geisinger Medical Center Danville Pennsylvania 17822 —
Geisinger Medical Center-Cancer Center Hazleton Hazleton Pennsylvania 18201 —
Geisinger Medical Group State College Pennsylvania 16801 —
Geisinger Wyoming Valley Wilkes-Barre Pennsylvania 18711 —
Women and Infants Hospital Providence Rhode Island 02905 —
Greenville Health System Cancer Institute-Faris Greenville South Carolina 29605 —
Greenville Health System Cancer Institute-Eastside Greenville South Carolina 29615 —
Greenville Health System Cancer Institute-Spartanburg Spartanburg South Carolina 29307 —
Avera Cancer Institute Sioux Falls South Dakota 57105 —
University of Virginia Charlottesville Virginia 22908 —
University of Wisconsin Hospital and Clinics Madison Wisconsin 53792 —
D N Greenwald Center Mukwonago Wisconsin 53149 —
Oconomowoc Memorial Hospital-ProHealth Care Inc Oconomowoc Wisconsin 53066-3896 —
Waukesha Memorial Hospital - ProHealth Care Waukesha Wisconsin 53188 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01220609, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 8, 2019 · Synced Nov 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.